T-cell receptor recognizing HIV-1 gp120 peptide-MHC class II complex (TCR-gp120-MHCII)

The T-cell receptor (TCR) recognizing HIV-1 gp120 peptide-MHC class II complexes is a critical molecular target in the development of immunotherapies and vaccines for HIV-1. This TCR, expressed on CD4+ T helper cells, mediates the recognition of processed fragments of the viral envelope glycoprotein gp120 presented by Major Histocompatibility Complex (MHC) class II molecules [PMID: 25143481]. This interaction is essential for orchestrating the adaptive immune response, as it triggers the activation of CD4+ T cells which provide necessary signals for B-cell maturation and the production of high-affinity neutralizing antibodies [PMID: 16148041]. In the natural course of HIV infection, these specific CD4+ T cells are often preferentially infected and depleted by the virus, leading to a failure of the immune system to control viral replication [PMID: 11752234]. Therapeutic strategies targeting this TCR include the use of recombinant gp120 vaccines to expand the population of reactive T cells and the engineering of TCR-T cells designed to recognize conserved viral epitopes [PMID: 30206130]. However, the high degree of sequence variability in the gp120 protein presents a significant challenge, as viral escape mutations can abrogate TCR recognition and render the immune response ineffective [PMID: 22438550].

Other names

gp120-specific T-cell receptorHIV-1 envelope-specific CD4+ TCRgp120-MHCII-specific TCRCD4+ T-cell receptor recognizing gp120-derived peptide-MHC class II complexes

Antigen-specific activation of CD4+ T lymphocytes to coordinate cellular and humoral immune responses against HIV-1.